The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

However, recent news represents a setback for Novavax's combined vaccine candidate. The U.S. Food and Drug Administration ...

Graeme Sloan / Bloomberg via Getty Images The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu shot because of safety concerns.

Novavax NVAX is scheduled to report third-quarter 2024 earnings on Nov. 12, before the opening bell. In the last reported ...

As a pediatric health care provider, it’s deeply disheartening to witness our state’s leaders squander an important ...

The revelation aired during Vance's interview on Joe Rogan's podcast episode with the potential next vice president.

This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...

Novavax doesn't require the extremely cold storage temperatures ... Eastern Health CEO David Diamond said his agency lost everything from basic email to diagnostic images and lab results. In 2021, ...